London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Looks like we could be back over a dollar soon enough at this rate.
GLA
GC about to buyout?
Wow +25% at one point.
Same subject, just now another tweet:
'Thank you @BWHNeurology for sharing the great news about the publication in @PNASNews featuring our lead asset Foralumab. The worlds only fully human, anti-CD3 mAb, which we are delivering nasally to #MS patients. We will be starting a full Phase 2 trial soon in #SPMS. $TLSA'
I know. It’s almost laughable. We all got suckered then they raised then never bothered with the trials and bad comms then said focusing on MS following the debacle with the delisting from the LSE and now back to covid again after burning ridiculous amounts of cash.
I just want this to bounce up a fair way so I can DUMP IT as fast as possible. Maybe they will sell out for billions of dollars, maybe not but I don’t have any faith in some of the connected parties here. Now you can see why some II’s steer clear of companies with one major holder.
Can't believe regurgitating covid again. We all got sucked in the UK, then they raised and delisted, buggering off with our proceeds. I still have no access to my shares with have be consolidated by 50% and on top of that the sp has again dropped also by 50%.
They've wasted over 2 years with all the shinnanagans so its just hoping upon hope......???
And still no IPO.
I wonder if we will get to 1000 days this year before IPO. Maybe more?
If market conditions are poor then RNS ABOUT IT FOR GOODNESS SAKE. Get the senior management team to give some interviews and explain what is happening day to day and when you plan to IPO.
The excitement about our nasally delivered, fully human anti-CD3 mAb continues. We will be starting a phase 2 trial using nasal Foralumab in patients with #MultipleSclerosis soon & will be looking into other CNS diseases including Orphan indications $TLSA
I notice Paul Spencer at the foot of the update as part of investor relations.
Congratulations, cant be any worse than what we had been getting and positively coupled with your background I'm hoping you can stem the leaking sp which has plagued this company.
Can I also suggest anyone involved in building rockets also apply for a position lol.
Just giving the pot a little stir...
…There might be life in the old dog yet…
I have thought for a while that they will try to get the sp above $1 for those 10 days, to stay on Nas, and this must be the start.
And an accompanying tweet:
Today We Announced a Publication in @PNASNews Illustrating the Immunological Basis of the Mechanism of Action for Intranasal Foralumab. We are very excited about the future of our main asset in #MultipleSclerosis and other CNS indications $TLSA #MS #SPMS tizianalifesciences.com/news-item?s=20…
https://www.proactiveinvestors.com/companies/news/1008424/tiziana-life-sciences-hails-publication-in-science-journal-of-article-on-mechanism-of-action-for-intranasal-foralumab-1008424.htmlDr Matthew W Davis, chief medical officer of Tiziana, said the upcoming quarter will be an “eventful and productive” period for Tiziana. “The publication of foralumab’s detailed mechanism of action dovetails with our forthcoming Alzheimer’s IND filing for intranasal foralumab and the Phase 2 FDA review comments for our proposed MS trial, all of which are expected this month,” Dr Davis said. “March will also be the third month of intranasal foralumab administration in four Expanded Access (EA 3 through EA 6) patients followed by data updates in Q2 2023.” He added that Tiziana remains on track to begin its Phase 2 intranasal foralumab non-active Secondary Progressive Multiple Sclerosis trial in the third quarter of this year. “I am thrilled that PNAS has chosen to publish this critical research on intranasal foralumab,” commented Gabriele Cerrone, executive chairman and interim chief executive officer of Tiziana. “Having an intranasal fully human monoclonal antibody that positively modulates the immune system allows Tiziana to explore multiple inflammatory disease indications in addition to multiple sclerosis (MS), and greatly increases the value of our groundbreaking research."
Because there are no updates at the moment. They did have an update in November, and they did announce the addition of three patients in January. I'm not sure why you keep posting, as if it is going to do something. We are all underwater. Nobody knows if things will work out or the stock will be delisted in June. Welcome to high-risk investing.
I’d be interested to know. Haven’t really heard a lot the last year or so. If they are riding out the biotech bear market that’s fine by me, but why not update investors about the market position.
Poor treatment by the board all round
Any update for this? It’s only been around 850 days since the Ex date in October 2020.
Say that again
Eight Hundred and Fifty Days.
For the record, no one can call me a ram per or de-ramper. I’m being honest in that I’m fed up but underwater, hope it increases so I can dump it all.
Does anyone know if we are lending Okyo more cash?
Huge spike on Okyo the other day, back down on its **** again now.
I hope Tiziana and accustem have a spike so I can dump my holding. I hope they then delist so some of the unscrupulous BOD lose all their cash, and more importantly their lifestyle business cash cow. All in my own opinion.
Keep in mind I have bought again recently accustem and tils, all with the hope I am “averaging down” so I can dump sooner and get out if there’s a spike.
As you say in you almost daily posts..
Maybe it's as if someone had been employed to raise the profile of the company and boost the SP..!! But as you say.. They don't need to employ someone to do this.. Especially not an ex plumber who knows more about the companies and has put more effort in over the years than anyone on here..
Can see that it has popped over 130% so far today, wonder what the situation is there.
MCAP almost double Tiziana now, and I thought they were running out of cash.
Let’s hope Tiziana gets a bit of a boost finally…
Or the biotech sector is starting to turn..